Cross Country Healthcare (CCRN)
(Delayed Data from NSDQ)
$17.11 USD
-0.44 (-2.51%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $17.12 +0.01 (0.06%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth F Momentum A VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
CCRN 17.11 -0.44(-2.51%)
Will CCRN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CCRN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CCRN
Cross Country (CCRN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Cross Country Healthcare (CCRN) Lags Q2 Earnings Estimates
CCRN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Do Options Traders Know Something About Cross Country Healthcare (CCRN) Stock We Don't?
Compared to Estimates, Cross Country (CCRN) Q1 Earnings: A Look at Key Metrics
New Strong Sell Stocks for February 27th
Other News for CCRN
Cross Country Healthcare (CCRN) Receives a Rating Update from a Top Analyst
Benchmark Co. Reaffirms Their Buy Rating on Cross Country Healthcare (CCRN)
Cross Country Healthcare (CCRN) Receives a Rating Update from a Top Analyst
Cross Country: Q2 Earnings Snapshot
Cross Country Healthcare Announces Second Quarter 2024 Financial Results